Last Thursday, the Centers for Medicare and Medicaid Services (CMS) announced that it would reverse course on anti-amyloid treatments for Alzheimer's patients and cover Leqembi should it receive full approval from the U.S. Food and Drug Administration (FDA). June is Alzheimer's Awareness month.
Leqembi, produced by Biogen and Eisai,...Arizona Comings & Goings
Brian Appavu, MD, has joined Barrow Neurological Institute at Phoenix Children’s as a neurointensivist and epileptologist. A former resident at PCH and Barrow at Phoenix Children’s, Dr. Appavu recently completed a neurophysicology fellowship in pediatric epilepsy from Columbia University Medical Center.Arizona Comings & Goings
